YieldMax MRNA Option Income Strategy ETF
This fund concentrates its exposure in one company, using derivatives rather than holding the shares directly. Its results depend on that single stock.
$38.48−0.35 (−0.90%)
History starts Oct 23, 2023.
- Expense ratio
- 1.00%
- Fund size
- $194M
- 1Y return
- +405.8%
- Yield · Last 12 months
- 42.04%
- Holdings
- 7
- Volume · 30D
- 0.3M sh
- NAV per share
- $36.90
- 52W range
The ETF.net MRNY Grade
Score 62 of 100 sits in the B band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.AScore 83Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.CScore 50Category rankRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.CScore 42Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.BScore 61Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.Not scoredDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.AScore 76Category rank
Our read on MRNY
BModerna, but with a job. MRNY sells weekly call spreads on MRNA and routes the premium out as a monthly distribution, keeping room for some upside through the spread's long leg. You still carry the stock's downside, without owning the shares.
MRNY is actively managed to generate weekly income by selling call spreads on Moderna Inc., while seeking participation in appreciation of the underlying share price.
Why people hold it
- Charges 1.00% a year, below the typical fee in its single-stock option-income peer group.
- Sells call spreads rather than plain calls, so the long leg leaves room to participate in part of a Moderna rally instead of surrendering all of it.yieldmaxetfs.com
- Options are written weekly and cash goes out monthly, an actively managed rhythm built around one stock's premium.
- Live since 2023, one of the earlier single-stock income funds in a category that has since crowded to dozens of tickers.
Worth knowing
- Synthetic exposure: you take Moderna's declines without holding the shares, and the short call caps how much of an advance the fund keeps.
- Payouts come from option premiums, which rise and fall with Moderna's option pricing. Monthly amounts vary rather than run at a set rate.
- The 1.00% fee buys the overlay and the active management, not a plain stake in the underlying stock.
MRNY Holdings
- Other
- 7
- 110%
- Cash & Other
MRNY Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
MRNY$50,580
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | MRNY |
|---|---|
| Year to date | +386.6% |
| 1 month | +22.4% |
| 3 months | +181.3% |
| 1 year | +405.8% |
| 3 years | — |
| 5 years | — |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | MRNY |
|---|---|---|
| 2026 YTD | +386.6% | |
| 2025 | −35.8% | |
| 2024 | −59.3% | |
| 2023 | +20.5% |
MRNY in the news
MRNY Dividends
- 42.04%
- $16.32
- $0.57 per share
- Weekly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Sep 17, 2026 | Sep 18, 2026 | $0.57 |
| Sep 10, 2026 | Sep 11, 2026 | $0.64 |
| Sep 3, 2026 | Sep 4, 2026 | $0.64 |
| Aug 27, 2026 | Aug 28, 2026 | $0.89 |
| Aug 20, 2026 | Aug 21, 2026 | $0.23 |
| Aug 13, 2026 | Aug 14, 2026 | $0.22 |
| Aug 6, 2026 | Aug 7, 2026 | $0.20 |
| Jul 30, 2026 | Jul 31, 2026 | $0.24 |
| Jul 23, 2026 | Jul 24, 2026 | $0.25 |
| Jul 16, 2026 | Jul 17, 2026 | $0.36 |
| Jul 9, 2026 | Jul 10, 2026 | $0.43 |
| Jul 2, 2026 | Jul 6, 2026 | $0.39 |
MRNY Risk
- 100.5%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.36
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −82.2%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- −0.09
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
MRNY Cost
1.00%
MRNY1.00%
- The middle half of Single-Stock Option Income funds
- Median 1.07%
14 of the 71 Single-Stock Option Income funds charge less.